Life Sciences International Review Q2 | 2018

June 2018

Welcome to the Q2 2018 issue of our Life Sciences International Review, produced by our life sciences lawyers in the US, Europe, and Asia and covering some of the most critical developments in the pharmaceutical and medical technology sectors in the last quarter.

In this issue, we cover updates relating to:

  • Intellectual Property
  • Exclusivity
  • Regulatory
  • Pricing and Reimbursement
  • Brexit News

Read the latest issue of the Life Sciences International Review >>